Previous studies have demonstrated that INDO, at a dose of 0.25 mM, begins to promote apoptosis of gastric cancer cells through the degradation of surviving and aurora-B proteins, related to resistance to apoptosis [36]. The gene discussed is AURKB; the disease is gastric cancer.